The negative inotropic action of catecholamines: Role of β3-adrenoceptors

Canadian Journal of Physiology and Pharmacology

Volumn 78, Issue 9, 2000, Pages 681-690

  Gauthier, C ^a   Leblais, V ^a   Moniotte, S ^a   Langin, D ^a   Balligand, J L ^a  

^a INSERM   (France)

Author keywords

Beta adrenoceptor; Contractility; Heart; Heart failure; Signaling pathway

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [(2 HYDROXY 2 PHENYLETHYL)AMINO]ETHOXY]PHENYLACETIC ACID; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ADRENERGIC RECEPTOR; ANTIDIABETIC AGENT; ANTIOBESITY AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 4 ADRENERGIC RECEPTOR; CATECHOLAMINE; DOBUTAMINE; ISOPRENALINE; METHYLENE BLUE; METOPROLOL; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NADOLOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PRAZOSIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER;

ADRENERGIC STIMULATION; CLONING; DOG; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; GUINEA PIG; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE POTENTIAL; HUMAN; INOTROPISM; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

EID: 0033807763     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y00-045     Document Type: Review

References (97)

1. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs
2. Beta 3-adrenoceptor in guinea pig brown and white adipocytes: Low expression and lack of function
3. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences
4. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
5. Cellular localization of endothelial constitutive nitric oxide synthase in ventricular myocytes from rat and human heart
6. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
7. 3-Adrenergic activation of adenylyl cyclase in mouse white adipocytes: Modulation by GTP and effect of obesity
8. 3-adrenoceptor rnRNA in human tissues
9. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog
10. In Vitro inhibition of intestinal motility by phenylethanolaminotetralines: Evidence of atypical beta-adrenoceptors in rat colon
11. 3-adrenergic receptor
12. β-Adrenoceptors in cardiac disease
13. Redox modulation of the L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols
14. The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: Direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle
15. Perinatal changes in the coupling of beta 1- and beta 3-adrenergic receptors to brown fat adenylyl cyclase
16. Differential interaction of beta 1- and beta 3-adrenergic receptors with Gi in rat adipocytes
17. 3-adrenergic receptors in the canine myocardium
18. 3 receptors and rat atrial receptors mediating tachycardia
19. Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines
20. Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells
21. Molecular characterization of the human beta 3-adrenergic receptor
22. The human beta 3-adrenoceptor: The search for a physiological function
23. Expression of beta 3-adrenoceptor mRNA in rat tissues
24. Beta 3-adrenoceptors in dog adipose tissue: Studies on their involvement in the lipomobilizing effect of catecholamines
25. 3-adrenoceptor in the human heart
26. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle
27. 3-adrenoceptor agonists
28. Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: New pharmacological profile and mechanism of activation
29. Beta 3-adrenoceptor: An update
30. Effects of TNF-alpha on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes
31. Molecular cloning and expression of the rat beta 3-adrenergic receptor
32. Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block
33. Characterization of the human beta 3-adrenergic receptor gene
34. 3-adrenoceptor. Transmembrane residues involved in ligand binding and signal transduction
35. Nitric oxide regulates rat heart contractile reserve by reversible post-translational modification of creatine kinase
36. Functional and structural complexity of signal transduction via G-protein-coupled receptors
37. 2+ current in adult rabbit atrioventricular nodal cells
38. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction
39. Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes
40. Is there a third heart β-adrenoceptor?
41. Four beta-adrenoceptor subtypes in the mammalian heart
42. Differences between the third cardiac β-adrenoceptor and the colonic β-adrenoceptor in the rat
43. Modulation of human cardiac function through 4 beta-adrenoceptor populations
44. 3-adrenoceptor knockout mice
45. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation
46. Functional assessment of white and brown adipocyte development and energy metabolism in cell culture. Dissociation of terminal differentiation and thermogenesis in brown adipocytes
47. Beta-1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue
48. Tissue distribution of β-adrenergic receptor mRNA in man
49. 3-adrenergic receptors expressed in native fat cells and in transfected cell lines
50. Differentiation of receptor systems activated by sympathomimetic amines
51. Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species
52. 3-adrenergic receptors parallels lipolysis in rat adipocytes
53. 3-Adrenoceptors control the cystic fibrosis transmembrane conductance regulator through a cAMP/PKA-independent pathway
54. 3-Adrenoceptors regulate CFTR conductance through a PTX-sensitive G protein
55. Molecular cloning of a human beta 3-adrenergic receptor cDNA
56. 3-adrenoceptor
57. 3 adrenergique humain et de rat exprimes dans la cellule CHO
58. - channels in heart
59. 3-adrenergic receptors: Differential agonist activation of recombinant receptors in chinese hamster ovary cells
60. 2-adrenergic receptor
61. 2-adrenoceptor-mediated effects
62. 3-adrenoceptors
63. Further heterogeneity of the beta-adrenoceptor. The phenylethanolaminotetralines: New selective agonists for atypical beta-adrenoceptors
64. New developments in β-adrenergic-mediated control of intestinal motility: Gut-specific phenylethanolaminotetralines
65. 3) β-adrenoceptors
66. Beta 3-adrenoceptors and airways
67. 2+ current is regulated by cGMP-dependent protein kinase in mammalian cardiac myocytes
68. 2+ current: Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation
69. 3-adrenoceptor and its coupled Gi-protein
70. An adipose tissue-specific beta-adrenergic receptor. Molecular cloning and down-regulation in obesity
71. Molecular characterization of the mouse beta 3-adrenergic receptor: Relationship with the atypical receptor of adipocytes
72. 3-adrenergic stimulation in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy
73. 3-adrenergic receptors
74. 3-adrenergic receptor
75. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
76. 2+ in intact cardiac myocytes
77. Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs
78. 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs
79. Beta3-adrenergic regulation of the L-type Ca2+ current in human atrial myocytes
80. The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a G(i)-dependent mechanism
81. 3-adrenoceptor
82. 3-adrenoceptor agonist in isolated, blood-perfused dog atria
83. The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms
84. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes
85. Inhibition of cytochrome c oxidase turnover by nitric oxide: Mechanism and implications for control of respiration
86. The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes
87. 3-adrenoceptor deletion mutations do not exhibit nitric oxide inhibition of myocardial contractility
88. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase
89. 3-adrenergic receptor in the obesity and diabetes prone rhesus monkey is very similar to human and contains arginine at codon 64
90. CFTR chloride channels in human and simian heart
91. Cystic fibrosis
92. 3-adrenoceptors in man
93. 3-adrenoceptor agonist BRL 35135 in man
94. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes
95. 2+ in cardiac myocytes
96. Effect of beta3-adrenergic stimulation on cardiac L-type calcium current: Normal vs congestive heart failure
97. 3-adrenoceptor coupled to lipolysis